RhoA-GTP pulldown activation assay (Cytoskeleton, #BK036) was carried out according to protocol. For western blots, protein extraction was performed using RIPA buffer (Sigma) supplemented with protease/phosphatase inhibitors. Cell lysates were incubated at 37°C for 1 hour in 2xSDS buffer prior to loading on SDS-PAGE. Commercial antibodies were used in accordance to manufacturer’s guidelines: anti-LGR5 (Abcam, ab75732), anti-GPR56 (Abnova, H00009289-B01P), anti-MDR1 (Abcam, ab170904 or Cell Signaling, 13342S), anti-MRP1 (Novus, NB400-156 or Cell Signaling, 72202S), anti-ABCG2 (Cell Signaling, 42078S), anti-myc (Cell Signaling, 2276S), and anti-β-actin (Cell Signaling, 4970). HRP-labeled secondary antibodies were utilized for detection with the standard ECL protocol. Quantification was performed using ImageJ.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.